Avandia decision could bolster rivals' sales
Marc Iskowitz
July 13 2010
Type 2 oral diabetes drugs from Takeda, Merck and other manufacturers stand to realize sales gains from today's FDA advisory ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.